Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes, Gestational | 7 | 2025 | 114 | 2.040 |
Why?
|
| Diet, High-Fat | 7 | 2025 | 254 | 1.010 |
Why?
|
| Leptin | 4 | 2016 | 219 | 1.000 |
Why?
|
| Receptors, Leptin | 3 | 2022 | 42 | 0.910 |
Why?
|
| Sugars | 2 | 2022 | 17 | 0.870 |
Why?
|
| Prenatal Exposure Delayed Effects | 5 | 2020 | 242 | 0.860 |
Why?
|
| Uterus | 2 | 2024 | 548 | 0.790 |
Why?
|
| Insulins | 1 | 2022 | 19 | 0.770 |
Why?
|
| Lipid Metabolism | 3 | 2020 | 381 | 0.760 |
Why?
|
| Placenta | 5 | 2022 | 540 | 0.730 |
Why?
|
| Endometriosis | 1 | 2024 | 175 | 0.710 |
Why?
|
| Endometrium | 1 | 2024 | 277 | 0.700 |
Why?
|
| Insulin Resistance | 3 | 2025 | 697 | 0.660 |
Why?
|
| Dietary Sucrose | 2 | 2018 | 41 | 0.660 |
Why?
|
| Fertility | 1 | 2022 | 258 | 0.650 |
Why?
|
| Fetal Development | 3 | 2020 | 132 | 0.640 |
Why?
|
| Pre-Eclampsia | 3 | 2020 | 230 | 0.640 |
Why?
|
| Pregnancy | 19 | 2025 | 7566 | 0.620 |
Why?
|
| Maternal Exposure | 2 | 2016 | 156 | 0.530 |
Why?
|
| Energy Metabolism | 1 | 2020 | 785 | 0.470 |
Why?
|
| Disease Models, Animal | 5 | 2025 | 4688 | 0.470 |
Why?
|
| Mice | 16 | 2025 | 18507 | 0.440 |
Why?
|
| Vascular Diseases | 1 | 2016 | 151 | 0.440 |
Why?
|
| Mice, Inbred C57BL | 10 | 2025 | 4757 | 0.390 |
Why?
|
| Food Deprivation | 1 | 2012 | 34 | 0.380 |
Why?
|
| Animals | 19 | 2025 | 34881 | 0.370 |
Why?
|
| Deoxyguanosine | 1 | 2011 | 13 | 0.360 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2011 | 22 | 0.350 |
Why?
|
| Embryo Implantation | 2 | 2024 | 231 | 0.350 |
Why?
|
| Adrenomedullin | 3 | 2022 | 80 | 0.340 |
Why?
|
| Obesity | 3 | 2025 | 2391 | 0.340 |
Why?
|
| Antioxidants | 1 | 2011 | 333 | 0.290 |
Why?
|
| Insulin | 4 | 2022 | 1168 | 0.280 |
Why?
|
| Female | 21 | 2025 | 70710 | 0.270 |
Why?
|
| Oxidative Stress | 1 | 2011 | 803 | 0.250 |
Why?
|
| Mice, Knockout | 3 | 2024 | 3863 | 0.250 |
Why?
|
| Pregnancy Complications | 2 | 2025 | 552 | 0.240 |
Why?
|
| Mitochondria, Liver | 1 | 2025 | 34 | 0.230 |
Why?
|
| Liver | 3 | 2025 | 1797 | 0.230 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2024 | 27 | 0.220 |
Why?
|
| Fallopian Tubes | 1 | 2024 | 76 | 0.200 |
Why?
|
| Postpartum Period | 1 | 2025 | 231 | 0.200 |
Why?
|
| Intra-Abdominal Fat | 2 | 2020 | 61 | 0.200 |
Why?
|
| Fatty Liver | 1 | 2025 | 211 | 0.200 |
Why?
|
| Parturition | 1 | 2022 | 66 | 0.180 |
Why?
|
| Progesterone | 1 | 2024 | 451 | 0.180 |
Why?
|
| Streptococcal Infections | 1 | 2024 | 248 | 0.180 |
Why?
|
| Glucose | 2 | 2022 | 878 | 0.180 |
Why?
|
| Receptors, Complement 3b | 1 | 2020 | 10 | 0.170 |
Why?
|
| Lipolysis | 1 | 2020 | 75 | 0.170 |
Why?
|
| Insulin-Secreting Cells | 1 | 2022 | 145 | 0.170 |
Why?
|
| Placentation | 1 | 2020 | 60 | 0.170 |
Why?
|
| Microbiota | 1 | 2024 | 434 | 0.150 |
Why?
|
| Mice, Transgenic | 1 | 2024 | 2445 | 0.140 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2019 | 145 | 0.140 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2020 | 490 | 0.140 |
Why?
|
| Spermatogenesis | 1 | 2018 | 176 | 0.130 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2017 | 63 | 0.130 |
Why?
|
| Animal Feed | 1 | 2017 | 79 | 0.130 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2017 | 50 | 0.130 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 684 | 0.130 |
Why?
|
| Glucose Intolerance | 1 | 2017 | 85 | 0.120 |
Why?
|
| Acetylcholine | 1 | 2016 | 84 | 0.120 |
Why?
|
| Testis | 1 | 2018 | 422 | 0.120 |
Why?
|
| Vascular Resistance | 1 | 2016 | 196 | 0.120 |
Why?
|
| Caloric Restriction | 1 | 2015 | 96 | 0.110 |
Why?
|
| Blood Pressure | 2 | 2020 | 1400 | 0.110 |
Why?
|
| Fibrosis | 1 | 2016 | 423 | 0.110 |
Why?
|
| Hair Color | 1 | 2012 | 12 | 0.100 |
Why?
|
| Genistein | 1 | 2012 | 39 | 0.100 |
Why?
|
| Phenols | 1 | 2012 | 57 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 1977 | 0.090 |
Why?
|
| Endocrine Disruptors | 1 | 2012 | 53 | 0.090 |
Why?
|
| Sex Factors | 1 | 2016 | 1353 | 0.090 |
Why?
|
| Benzhydryl Compounds | 1 | 2012 | 68 | 0.090 |
Why?
|
| Motor Activity | 1 | 2015 | 523 | 0.090 |
Why?
|
| Apoptosis | 1 | 2018 | 1892 | 0.090 |
Why?
|
| Body Weight | 1 | 2015 | 994 | 0.090 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2016 | 417 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2020 | 2493 | 0.080 |
Why?
|
| Transcriptome | 1 | 2015 | 1125 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 1163 | 0.060 |
Why?
|
| Humans | 7 | 2025 | 132061 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2012 | 554 | 0.060 |
Why?
|
| Streptococcus | 1 | 2024 | 63 | 0.050 |
Why?
|
| Gene Expression | 2 | 2020 | 1558 | 0.050 |
Why?
|
| Streptococcus agalactiae | 1 | 2024 | 103 | 0.050 |
Why?
|
| Insulin, Regular, Human | 1 | 2022 | 12 | 0.050 |
Why?
|
| Receptors, Adrenomedullin | 1 | 2022 | 16 | 0.050 |
Why?
|
| Vagina | 1 | 2024 | 205 | 0.050 |
Why?
|
| Autophagy | 1 | 2025 | 426 | 0.050 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2024 | 253 | 0.040 |
Why?
|
| Complement Inactivating Agents | 1 | 2020 | 13 | 0.040 |
Why?
|
| Receptors, Complement | 1 | 2020 | 32 | 0.040 |
Why?
|
| Complement Activation | 1 | 2020 | 49 | 0.040 |
Why?
|
| Complement C3 | 1 | 2020 | 51 | 0.040 |
Why?
|
| Male | 5 | 2018 | 64920 | 0.040 |
Why?
|
| Trophoblasts | 1 | 2020 | 117 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 2438 | 0.040 |
Why?
|
| Perilipin-1 | 1 | 2019 | 7 | 0.040 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2019 | 9 | 0.040 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2019 | 20 | 0.040 |
Why?
|
| Calcitonin Receptor-Like Protein | 1 | 2019 | 22 | 0.040 |
Why?
|
| Dietary Sugars | 1 | 2019 | 16 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2020 | 213 | 0.040 |
Why?
|
| Receptor, Insulin | 1 | 2019 | 68 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2019 | 152 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 687 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 385 | 0.040 |
Why?
|
| Sperm Count | 1 | 2018 | 91 | 0.030 |
Why?
|
| Cytokines | 1 | 2024 | 1358 | 0.030 |
Why?
|
| Binding Sites | 1 | 2020 | 1256 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2020 | 527 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 573 | 0.030 |
Why?
|
| Biomarkers | 1 | 2025 | 3406 | 0.030 |
Why?
|
| PPAR alpha | 1 | 2015 | 53 | 0.030 |
Why?
|
| Exploratory Behavior | 1 | 2015 | 55 | 0.030 |
Why?
|
| Pancreas | 1 | 2016 | 222 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2019 | 800 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2025 | 1408 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 1035 | 0.030 |
Why?
|
| Metabolic Diseases | 1 | 2015 | 139 | 0.030 |
Why?
|
| Triglycerides | 1 | 2016 | 617 | 0.030 |
Why?
|
| Eating | 1 | 2015 | 381 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2012 | 162 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 1284 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 541 | 0.020 |
Why?
|
| Mutation | 2 | 2016 | 6229 | 0.020 |
Why?
|
| Gestational Age | 1 | 2015 | 1224 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 713 | 0.020 |
Why?
|
| Risk Factors | 1 | 2025 | 10941 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 1548 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 6448 | 0.010 |
Why?
|